Pulmonary and neurologic complications of treatment with FIAC (2'fluoro-5-iodo-aracytosine) in patients with acquired immune deficiency syndrome (AIDS).
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D003561:Cytarabine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000150:complications / Q000188:drug therapy; D005260:Female; D006566:Herpesviridae Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000139:chemically induced*; D011019:Pneumonia, Mycoplasma / Q000209:etiology; D011020:Pneumonia, Pneumocystis / Q000209:etiology*
D003561:Cytarabine; C026023:fiacitabine